Breast cancer: targeting the genome for better surveillance and

Genetic Contribution to Breast Cancer: A Critical Analysis of Penetrance Alleles as Susceptible Genes

Molecular profiling for precision cancer therapies, Genome Medicine

Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression

IJMS, Free Full-Text

Cells, Free Full-Text

Identifying ESR1 Mutations to Determine Resistance in HR+ Metastatic Breast Cancer- Cancer Therapy Advisor

Frontiers Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More

Cancer genomics Genomics England

Preventing Resistance to Cancer Targeted Therapies - NCI

Genomic landscape and characteristics of prospectively sequenced

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

Heterogeneity in precision oncology, Cambridge Prisms: Precision Medicine

Long-read sequencing: the key to a more complete cancer transcriptome - PacBio

PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652 - ScienceDirect

IJMS, Free Full-Text